Orchid Pharma receives US FDA approval for Naratriptan tablets

MUMBAI: The Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals Ltd today announced that it has received approval from US FDA for its ANDA ( Abbreviated New Drug Application) for Naratriptan tablets in the 1 mg and 2.5 mg strengths.

Naratriptan tablets are the generic equivalent of GSK's Amerge tablets, a company statement said here.

Orchid Chemicals is a leading pharmaceutical company engaged in the development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals.

With exports spanning more than 75 countries, Orchid is the largest manufacturer-exporter of cephalosporin bulk actives in India and is ranked amongst the Top 5-cephalosporin producers in the world.